Acasti Pharma Inc (NASDAQ:ACST)

0.71
Delayed Data
As of May 18
 +0.0111 / +1.59%
Today’s Change
0.60
Today|||52-Week Range
3.36
-24.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues478.6K240.5K28.8K0.00
 
 
 
 
Cost of Goods Sold278.9K208.9K62.3K0.00
 
 
 
 
Depreciation And Amortization1.7M2.1M1.8M1.9M
 
 
 
 
 
 
Operating ExpensesGross Income-1.5M-2.0M-1.9M-1.9M
 
 
 
 
 
General Expenses9.1M9.2M5.4M6.0M
 
 
 
 
 
Research And Development4.4M6.0M3.7M5.4M
 
 
 
 
 
Total Operating Expenses11.1M11.5M7.3M7.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-10.6M-11.2M-7.2M-7.9M
 
 
 
 
 
Extraordinary Credit--7.8M1.7M0.00
 
 
 
Extraordinary Charge-484.9K---259.5K-40.4K
 
 
 
 
Interest Expense On Debt----0.0040.8K
 
 
Other Expenses-321.8K1.6M780.7K-123.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.4M-1.7M-5.0M-8.0M
 
 
 
 
 
Income Taxes-257.6K-234.9K-129.2K-90.7K
 
 
 
 
 
Net Income-11.1M-1.5M-4.8M-7.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.4M10.6M10.7M11.1M
 
 
 
 
 
Shares To Calculate EPS Diluted8.4M10.6M10.7M11.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.34-$0.18-$0.45-$0.77
 
 
 
 
 
EPS Diluted-$1.34-$0.18-$0.45-$0.71